BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 16690430)

  • 1. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance.
    Liang SX; Zhu XD; Xu ZY; Zhu J; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):426-34. PubMed ID: 16690430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma.
    Xu ZY; Liang SX; Zhu J; Zhu XD; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):189-95. PubMed ID: 16542787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.
    Cheng JC; Wu JK; Lee PC; Liu HS; Jian JJ; Lin YM; Sung JL; Jan GJ
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1502-9. PubMed ID: 15590181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma.
    Liang SX; Zhu XD; Lu HJ; Pan CY; Li FX; Huang QF; Wang AY; Chen L; Fu XL; Jiang GL
    Cancer; 2005 May; 103(10):2181-8. PubMed ID: 15812834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease.
    Cheng JC; Liu HS; Wu JK; Chung HW; Jan GJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1150-6. PubMed ID: 15990021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
    Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child-Pugh Grade A cirrhosis.
    Liang SX; Huang XB; Zhu XD; Zhang WD; Cai L; Huang HZ; Li YF; Chen L; Liu MZ
    Radiother Oncol; 2011 Feb; 98(2):265-9. PubMed ID: 21056489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factor of primary liver cancer treated by hypofractionated three-dimensional conformal radiotherapy].
    Liang SX; Jiang GL; Zhu XD; Fu XL; Li FX; Huang QF; Wang AY; Chen L; Lu HJ
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):613-5. PubMed ID: 16438872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial volume tolerance of the liver to radiation.
    Dawson LA; Ten Haken RK
    Semin Radiat Oncol; 2005 Oct; 15(4):279-83. PubMed ID: 16183482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of radiation induced liver disease using artificial neural networks.
    Zhu J; Zhu XD; Liang SX; Xu ZY; Zhao JD; Huang QF; Wang AY; Chen L; Fu XL; Jiang GL
    Jpn J Clin Oncol; 2006 Dec; 36(12):783-8. PubMed ID: 17068085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial.
    Mornex F; Girard N; Beziat C; Kubas A; Khodri M; Trepo C; Merle P
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1152-8. PubMed ID: 17145534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication.
    Son SH; Choi BO; Ryu MR; Kang YN; Jang JS; Bae SH; Yoon SK; Choi IB; Kang KM; Jang HS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1073-80. PubMed ID: 20207492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative dose of radiation therapy of hepatocellular carcinoma patients and its deterministic relation to radiation-induced liver disease.
    Huang P; Yu G; Kapp DS; Bian XF; Ma CS; Li HS; Chen JH; Liang YQ; Zhang Y; Qin SH; Xie YQ; Yang Y; Yin Y; Xing L; Li DW
    Med Dosim; 2018 Autumn; 43(3):258-266. PubMed ID: 29198389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].
    Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapolation of normal tissue complication probability for different fractionations in liver irradiation.
    Tai A; Erickson B; Li XA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):283-9. PubMed ID: 19289259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tolerance and efficacy of conformal radiotherapy for hepatocellular carcinoma in cirrhotic patients. Results of the French RTF1 phase II trial].
    Mornex F; Girard N; Merle P; Béziat C; Kubas A; Wautot V; Khodri M; Trepo C
    Cancer Radiother; 2005 Nov; 9(6-7):470-6. PubMed ID: 16219480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reappraisal of risk factors predicting liver complications from radiotherapy for hepatocellular carcinoma].
    Lee IJ; Seong J; Shim SJ; Han KH; Chon CY
    Korean J Hepatol; 2006 Sep; 12(3):420-8. PubMed ID: 16998294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of dosimetric variations of liver radiotherapy using deformable registration of planning CT and cone-beam CT.
    Huang P; Yu G; Chen J; Ma C; Qin S; Yin Y; Liang Y; Li H; Li D
    J Appl Clin Med Phys; 2017 Jan; 18(1):66-75. PubMed ID: 28291931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.